Merck shares were trading above $45 a share before the Vioxx recall late last month.
Vioxx belonged to a class of drugs called Cox-2 inhibitors.
FDA requests more safety data on Merck's successor to Vioxx The review also will consider whether additional studies are needed.
Merck's stock closed at $26.21 Friday, down 81 cents for the day and now down nearly 42 percent since Vioxx was withdrawn.
Goldenberg is among doctors who believe all Cox-2 inhibitors carry some cardiovascular risk, despite assertions from Pfizer that Celebrex and Bextra are fine.
Arthritis pain relief your stomach can live with, says the
